Affimed
AFMD
#10629
Rank
โ‚น0.27 B
Marketcap
โ‚น16.95
Share price
0.00%
Change (1 day)
-71.57%
Change (1 year)

Earnings for Affimed (AFMD)

Earnings in 2024 (TTM): -โ‚น6.39 Billion

According to Affimed 's latest financial reports the company's current earnings are โ‚น0.96 Million. In 2023 the company made an earning of -โ‚น10.74 Billion a decrease over its 2022 earnings that were of -โ‚น8.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Affimed from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น6.39 Billion-40.56%
2023 -โ‚น10.74 Billion26.6%
2022 -โ‚น8.48 Billion36.51%
2021 -โ‚น6.22 Billion38.05%
2020 -โ‚น4.5 Billion33.51%
2019 -โ‚น3.37 Billion54.17%
2018 -โ‚น2.19 Billion-32.35%
2017 -โ‚น3.24 Billion-3.51%
2016 -โ‚น3.35 Billion60.24%
2015 -โ‚น2.09 Billion3296.68%
2014 -โ‚น61.52 Million-98.1%
2013 -โ‚น3.24 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
โ‚น7.83 B-209.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-โ‚น0.22 Billion-97.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น1.92 B-127.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚น25.38 Billion 255.38%๐Ÿ‡บ๐Ÿ‡ธ USA